First-line Combination Treatment Based on Anlotinib
Clinical trial NCT03628521 · UNKNOWN
Trial details
- NCT number
- NCT03628521
- Sponsor
- Shanghai Chest Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-20
- Primary completion
- 2019-12-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.